Roivant Sciences Ltd. ( ROIV) - Stock Earnings
ROIV Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -265.9 million USD | 2.0 million USD |
| 2026Q1 | 303.0 million USD | 2.5 million USD |
| 2026Q2 | -189.8 million USD | 1.4 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ROIV Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | 4.3 billion USD | 32.7 million USD |
| 2025 | -172.0 million USD | 29.1 million USD |
| 2026 | -299.8 million USD | 8.3 million USD |
| 2026 Est. | — | — |
ROIV
Price: $35.72
52 week price:
Earnings Per Share: -0.47 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 1.4 million
Market Capitalization: 25.0 billion